|
Pancreatic cancer is a malignant neoplasm of the pancreas. By the end of 2010 in the United States is estimated that about 43,140 individuals will be diagnosed with this condition and 36,800 will die from the disease.[1] The prognosis is relatively poor but has improved; the three-year survival rate is now about thirty percent, but fewer than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still rather rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, signet ring cell carcinomas, hepatoid carcinomas, colloid carcinomas, undifferentiated carcinomas, and undifferentiated carcinomas with osteoclast-like giant cells. Exocrine pancreatic tumors are far more common than pancreatic endocrine tumors, which make up about 1% of total cases.
(Rated by 1 Council Member)
|
